My earlier blog outlined BMJ reader feedback to the two updated Cochrane reviews on the benefits and harms in influenza of the neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza). But the two research articles also […]
NEJM 10 Apr 2014 Vol 370 OL A deadly virus has been conquered. Hepatitis C genotype 1 can be cleared with a simple oral combination treatment, and compared to that, […]
Gathering evidence is clear straightforward science. Right? Not if you believe the speakers at “Evidence Live.” Today’s presentations were a challenge to believers. Fraud, misconduct, non disclosure of data, and […]
NEJM 1 Nov 2012 Vol 367 1677 Cancer screening campaigns—getting past uninformative persuasion is a topical subject on both sides of the Atlantic. Nobody writes better about it than Steven […]
“The same standard of openness should apply to all (drug) trial data, whether sponsored by industry, investigator-initiated, or sponsored by public grant-giving bodies.” That’s the view of representatives from the […]
During the first wave of the pandemic, patient facing healthcare workers and their families were statistically more likely to be admitted to hospital with covid-19 than non-patient facing staff or […]
The current question “to mask or not to mask?” has again unmasked our limitations in interpreting medical research and in handling the associated uncertainty, argues James Brophy […]
While we are all self-isolating, people are starting to think about autarky, self-sufficiency. For example, that doyen of ancient Greek and Roman history as a reflection on modern affairs, Peter […]
Where’s little Ava?” I asked. Strange – it seemed I should know the answer to that. Hadn’t she just been in my arms, nursing? I felt light-headed, but it had […]
Anna Howells introduces 2100: A Health Odyssey, the science-fiction writing competition breathing life into the discussion about healthcare, past, present and future. Return to BMJ Opinion over the next week […]
